tirzepatide alcohol cravings GLP-1 medications: The next big thing in use disorder treatment? – Recovery Research Institute Could a medication used for

Available from Accessed 25 November 2019 Sorli C, Harashima SI, Tsoukas GM et al (2017) Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial

Traditional Chinese medicine enables the development of small-molecule inhibitors of HSP47, future therapeutic implication in venous thromboembolism

The bakery industry (long associated with indulgence and high-calorie products) and the snacks sectors (heavily reliant on impulse purchases) are particularly vulnerable to the shift in consumer preferences

doi: 10.1097/MCG.0000000000000666 18 DaiWYeLLiuAWenSWDengJWuXet al

The resulting active compounds cause damage to the cells in the lining of the intestine and leads to apoptosis (a form of cell death)